New Age Alpha Advisors LLC Invests $247,000 in Cabot Co. (NYSE:CBT)

New Age Alpha Advisors LLC purchased a new position in Cabot Co. (NYSE:CBT) in the fourth quarter, Holdings Channel.com reports. The fund purchased 2,709 shares of the specialty chemicals company’s stock, valued at approximately $247,000.

Several other large investors have also added to or reduced their stakes in CBT. R Squared Ltd purchased a new stake in shares of Cabot in the 4th quarter worth about $26,000. EverSource Wealth Advisors LLC lifted its holdings in Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock worth $74,000 after buying an additional 219 shares during the period. GAMMA Investing LLC boosted its position in Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock valued at $123,000 after acquiring an additional 130 shares in the last quarter. Manchester Capital Management LLC grew its holdings in shares of Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock worth $153,000 after acquiring an additional 1,584 shares during the period. Finally, KBC Group NV raised its position in shares of Cabot by 43.1% in the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock worth $187,000 after acquiring an additional 616 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Wall Street Analyst Weigh In

CBT has been the topic of several recent research reports. JPMorgan Chase & Co. reduced their price target on Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Mizuho decreased their price target on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, January 7th. Finally, StockNews.com raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $97.00.

Cabot Price Performance

Shares of NYSE:CBT opened at $84.40 on Thursday. The company has a market capitalization of $4.58 billion, a PE ratio of 11.21, a PEG ratio of 0.74 and a beta of 1.21. The business has a fifty day moving average price of $85.23 and a 200-day moving average price of $97.76. Cabot Co. has a 1-year low of $79.57 and a 1-year high of $117.46. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29.

Cabot (NYSE:CBT) last posted its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. As a group, equities analysts expect that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 2.04%. The ex-dividend date of this dividend was Friday, February 28th. Cabot’s dividend payout ratio is currently 22.84%.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.